Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004026902 | SCV000850833 | uncertain significance | not specified | 2021-12-20 | criteria provided, single submitter | clinical testing | The c.957A>C (p.E319D) alteration is located in exon 12 (coding exon 11) of the KATNAL2 gene. This alteration results from a A to C substitution at nucleotide position 957, causing the glutamic acid (E) at amino acid position 319 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004705778 | SCV005215406 | likely benign | not provided | criteria provided, single submitter | not provided |